These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6637663)

  • 21. [Glomerular localization of the early components of complement in glomerulonephritis].
    Barbiano di Belgiojoso G; Tarantino A; Durante A; Guerra L
    Minerva Nefrol; 1974; 21(3):169-78. PubMed ID: 4463297
    [No Abstract]   [Full Text] [Related]  

  • 22. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ
    J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The classical complement pathway: mechanism of activation of the first component by antigen-antibody complexes.
    Loos M
    Prog Allergy; 1982; 30():135-92. PubMed ID: 7041131
    [No Abstract]   [Full Text] [Related]  

  • 24. Schistosoma mansoni: the role of the complement C3-activating system in the cercaricidal action of normal serum.
    Machado AJ; Gazzinelli G; Pellegrino J; Dias de Silva W
    Exp Parasitol; 1975 Aug; 38(1):20-9. PubMed ID: 807484
    [No Abstract]   [Full Text] [Related]  

  • 25. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction.
    Pinckard RN; Olson MS; Giclas PC; Terry R; Boyer JT; O'Rourke RA
    J Clin Invest; 1975 Sep; 56(3):740-50. PubMed ID: 808560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guinea pigs deficient in C2, C4, C3 or the C3a receptor.
    Bitter-Suermann D; Burger R
    Prog Allergy; 1986; 39():134-58. PubMed ID: 3550815
    [No Abstract]   [Full Text] [Related]  

  • 27. Function of the activated fourth component of complement (C4b) in activation of C2.
    Vogt W; Hinsch B; Schmidt G; von Zabern I
    FEBS Lett; 1982 Aug; 144(2):195-8. PubMed ID: 6981526
    [No Abstract]   [Full Text] [Related]  

  • 28. Complement deposition in glomerular diseases.
    di Belgiojoso GB; Tarantino A; Durante A; Guerra L
    Proc Eur Dial Transplant Assoc; 1975; 11():515-21. PubMed ID: 1105561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The detection of activity of components and factors of complement according its effect on infusorians].
    Kuleshina ON; Kozlov LV
    Klin Lab Diagn; 2015 Jan; 60(1):56-9. PubMed ID: 25874307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies.
    Vanguri P; Koski CL; Silverman B; Shin ML
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3290-4. PubMed ID: 6954480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoglobulin and complement deposits in lupus glomerulonephritis.
    Méry JP; Morel-Maroger L; Boelaert J
    Proc Eur Dial Transplant Assoc; 1975; 11():506-11. PubMed ID: 1197274
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of macrophage activation on the synthesis of complement components C2, C3, C4.
    Hartung HP; Zanker B; Bitter-Suermann D
    Adv Exp Med Biol; 1982; 155():525-9. PubMed ID: 7158498
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunohistological studies of renal diseases. II. The clinical and histopathological significance of complement deposition in glomeruli (author's transl)].
    Sato M
    Nihon Jinzo Gakkai Shi; 1980 Oct; 22(10):1347-60. PubMed ID: 7017209
    [No Abstract]   [Full Text] [Related]  

  • 34. [Direct reaction between complement system and cell nuclei (author's transl)].
    Peltier AP; Cyna L; Solal LC; Dryll A
    Ann Immunol (Paris); 1975; 126(2):177-89. PubMed ID: 172006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Complement system in glomerulonephritis. II. Detailed aspects].
    Bodalski J; Narebska E; Jerzmanowski A
    Pediatr Pol; 1980 Jun; 55(6):805-11. PubMed ID: 7413331
    [No Abstract]   [Full Text] [Related]  

  • 36. The complement system and nephritis.
    Müller-Eberhard HJ
    Adv Nephrol Necker Hosp; 1974; 4():3-14. PubMed ID: 4143384
    [No Abstract]   [Full Text] [Related]  

  • 37. Hereditary angio-oedema: its pathogenesis and management.
    Ballogh Z; Whaley K
    Scott Med J; 1980 Jul; 25(3):187-95. PubMed ID: 7444430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Participation of an early component of complement and Hageman factor in C3 destruction by zymosan.
    Gigli I; Koethe S; Austen KF
    Clin Immunol Immunopathol; 1975 Jul; 4(2):189-98. PubMed ID: 1170051
    [No Abstract]   [Full Text] [Related]  

  • 39. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
    Geiger H; Good RA; Day NK
    Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum and glomerular complement in 205 cases of glomerulonephritis.
    Durante A; Rovati C; di Belgiojoso GB; Minetti L
    Proc Eur Dial Transplant Assoc; 1976; 12():189-96. PubMed ID: 935112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.